Experimental drug aims to restore platelets in Heparin-Triggered disorder
Disease control
Terminated
This study tested an experimental drug called VLX-1005 in people with a rare condition where the blood thinner heparin causes a dangerous drop in platelets (cells that help blood clot). Participants received either VLX-1005 or a placebo alongside standard care. The goal was to se…
Phase: PHASE2 • Sponsor: Veralox Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC